Laura Hulea

3.8k total citations · 1 hit paper
21 papers, 2.0k citations indexed

About

Laura Hulea is a scholar working on Molecular Biology, Cancer Research and Hematology. According to data from OpenAlex, Laura Hulea has authored 21 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 6 papers in Cancer Research and 3 papers in Hematology. Recurrent topics in Laura Hulea's work include PI3K/AKT/mTOR signaling in cancer (8 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Metabolism, Diabetes, and Cancer (4 papers). Laura Hulea is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (8 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Metabolism, Diabetes, and Cancer (4 papers). Laura Hulea collaborates with scholars based in Canada, United States and Sweden. Laura Hulea's co-authors include Ivan Topisirović, Nahum Sonenberg, Jerry Pelletier, Nathaniel Robichaud, Mamatha Bhat, Julie St‐Pierre, Ola Larsson, Michaël Pollak, Masahiro Morita and Simon‐Pierre Gravel and has published in prestigious journals such as Nature Communications, Molecular Cell and Nature Reviews Drug Discovery.

In The Last Decade

Laura Hulea

19 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting the translation machinery in cancer

2015 597 citations Mamatha Bhat, Nathaniel Robichaud et al. Nature Reviews Drug Discovery profile →

Peers

Countries citing papers authored by Laura Hulea

Since Specialization

Citations

This map shows the geographic impact of Laura Hulea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Hulea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Hulea more than expected).

Fields of papers citing papers by Laura Hulea

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Hulea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Hulea. The network helps show where Laura Hulea may publish in the future.

Co-authorship network of co-authors of Laura Hulea

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Hulea. A scholar is included among the top collaborators of Laura Hulea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Hulea. Laura Hulea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Translational control of leukemic metabolism and disease progression	Trends in Cell Biology	François Mercier, Raquel Aloyz et al.	0
2	Protocol to perform polysome profiling in primary differentiating murine adipocytes	STAR Protocols	Mirian Krystel De Siqueira, Siqi Wang et al.	0
3	ZO-1 interacts with YB-1 in endothelial cells to regulate stress granule formation during angiogenesis	Nature Communications	Rony Chidiac, Chantal Delisle et al.	15
4	The mitochondrial pyruvate carrier complex potentiates the efficacy of proteasome inhibitors in multiple myeloma	Blood Advances	Remya Nair, Ronald A. Merrill et al.	9
5	EIF4A inhibition targets bioenergetic homeostasis in AML MOLM-14 cells in vitro and in vivo and synergizes with cytarabine and venetoclax	Journal of Experimental & Clinical Cancer Research	Gabriela Galicia-Vázquez, Alejandro Schcolnik‐Cabrera et al.	13
6	Mitochondrial complex IV defects induce metabolic and signaling perturbations that expose potential vulnerabilities in HCT116 cells	FEBS Open Bio	Alexander V. Zhdanov, Predrag Jovanović et al.	7
7	Perturbations of cancer cell metabolism by the antidiabetic drug canagliflozin	Neoplasia	David Papadopoli, Laura Hulea et al.	40
8	Oncogenic kinases and perturbations in protein synthesis machinery and energetics in neoplasia	Journal of Molecular Endocrinology	Michaël Pollak, Ivan Topisirović et al.	8
9	Translational and HIF11-Dependent Metabolic Reprograming Underpin Oncometabolome Plasticity and Synergy Between Oncogenic Kinase Inhibitors and Biguanides	SSRN Electronic Journal	Laura Hulea, Simon‐Pierre Gravel et al.	1
10	mTOR Controls Mitochondrial Dynamics and Cell Survival via MTFP1	Molecular Cell	Masahiro Morita, Julien Prudent et al.	262
11	mTOR-sensitive translation: Cleared fog reveals more trees	RNA Biology	Laìa Masvidal, Laura Hulea et al.	50
12	nanoCAGE reveals 5′ UTR features that define specific modes of translation of functionally related MTOR-sensitive mRNAs	Genome Research	Valentina Gandin, Laìa Masvidal et al.	144
13	Biomedical Potential of mTOR Modulation by Nanoparticles	Trends in biotechnology	Laura Hulea, Zoran Marković et al.	29
14	The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway	Nature Communications	Marie‐Eve Lalonde, Marie-Anne Germain et al.	137
15	SBI-0640756 Attenuates the Growth of Clinically Unresponsive Melanomas by Disrupting the eIF4F Translation Initiation Complex	Cancer Research	Yongmei Feng, Anthony B. Pinkerton et al.	26
16	Targeting the translation machinery in cancer breakdown →	Nature Reviews Drug Discovery	Mamatha Bhat, Nathaniel Robichaud et al.	597
17	mTOR coordinates protein synthesis, mitochondrial activity and proliferation	Cell Cycle	Masahiro Morita, Simon‐Pierre Gravel et al.	401
18	RAS Transformation Requires CUX1-Dependent Repair of Oxidative DNA Damage	PLoS Biology	Zubaidah M. Ramdzan, Charles Vadnais et al.	53
19	Serine Deprivation Enhances Antineoplastic Activity of Biguanides	Cancer Research	Simon‐Pierre Gravel, Laura Hulea et al.	105
20	CUX1 transcription factors: From biochemical activities and cell-based assays to mouse models and human diseases	Gene	Laura Hulea, Alain Nepveu	61

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact